Signature Genomic Laboratories Introduces Patient Advocacy Program
Posted on: Wednesday, 2 April 2008, 15:00 CDT
Signature Genomic Laboratories, LLC, has introduced a Patient Advocacy Program to assist patients and their families with obtaining insurance coverage for microarray analysis. Through the program, Signature's Patient Advocacy Team will communicate with the patient's insurance carrier on the patient's behalf to determine the benefits available for clinical laboratory testing. If the insurance carrier refuses to pay for all or part of the charge, the Patient Advocacy Team will work with the patient to submit an appeal or develop an alternate payment plan.
"We want to ensure that patients have the ability to receive the diagnostic care they need from Signature," said Catherine D. Kashork, Director of Operations at Signature. "The Patient Advocacy Program removes one more barrier to patients getting access to health care."
About Signature Genomic Laboratories, LLC
Signature Genomic Laboratories, founded in 2003, was the first laboratory to provide microarray-based cytogenetic diagnostics with its proprietary SignatureChip® and is the leader in providing microarray-based chromosome analysis. Signature's worldwide client base includes clinical geneticists, neurologists, pediatricians, neonatologists, obstetricians, and the research community. Signature is CAP accredited, CLIA certified, and licensed in the state of Washington. Additional information about Signature is available at www.signaturegenomics.com.
Source: Business Wire
Related Articles
- New Google Health Application Helps Users Find Patient Assistance Programs for Medications Using PatientAssistance.Com
- The Doctors Company Launches New Patient Safety Program for Obstetricians to Help Reduce Risk and Improve Quality of Patient Care
- VeriChip Corporation Launches New ``Patient First'' Program for Its VeriMed Patient Identification System
- Delaware Cancer Patients Among Nation's First to Benefit From Expansion of the American Cancer Society's 'Patient Navigator Program'
- Government Approves Lilly's Medicare Part D Patient Assistance Program
- Partnership for Prescription Assistance Hits Milestone By Connecting 2.5 Million Patients to Patient Assistance Programs
- Merck to Create New Patient Assistance Program for Vaccines
- HHS Applauds Pharmaceutical Patient Assistance Programs
- The Merck Patient Assistance Program Remains an Option for Many Medicare Beneficiaries
- ProMutual Group Expands Successful Patient Safety Program
 |
 |
User Comments (0)
RSS Feeds